The Cancer Test Too Many Patients Still Aren't Getting — And Why It Matters

Biomarker testing is helping turn personalized medicine from an idea into a reality — yet too many cancer patients still aren’t getting it. Dr. Nathan Fowler explains why this testing matters, what it can reveal, and how it can change treatment decisions.

Sign up to receive my newsletter and to learn about upcoming podcasts with leading research scientists where we will identify promising new anti-cancer therapies.

Your information will not be shared and it will not be used for promotional purposes.

The information on this site is provided solely for educational purposes.

I’m not a licensed or accredited physician, therapist, or clinical researcher. This information is not intended as medical advice and it is not a substitute for the advice of a physician, therapist, nutritionist, or other qualified healthcare professional. The strategies discussed on this website and in all materials produced by Outperform Cancer are not to replace medical treatment.

Whether you choose conventional treatments, alternative treatments, or both, it is imperative that you work closely with a doctor or healthcare professional to properly diagnose and treat your condition, and to monitor your progress.

Neither Outperform Cancer, nor its guests, researchers, physicians, employees, or affiliates assume any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process described on this website. Outperform Cancer disclaims any liability, loss, or risk, personal or otherwise, that is incurred as a direct or indirect consequence of the information contained on this site.